Gene · 1375
Papers1,685
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,685
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondrial bioenergetics-SASP crosstalk determines senolytic efficacy in therapy-induced senescence. | Cell Death Discov | 2026 | 41714592 | PubTator, text mining | PubMed |
| Nanobody-based IgG simultaneously inhibit the allergenic and enzymatic activity of the dominant honeybee venom allergen. | Nat Commun | 2026 | 41702899 | PubTator, text mining | PubMed |
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| SIRT3-dependent enhancement of apelinergic signaling mediates the cardioprotective effects of late-life high-intensity interval training. | J Physiol Sci | 2026 | 41619329 | PubTator, text mining | PubMed |
| Research progress on the effects of macrophage‑derived exosomes on muscle factors IGF‑1 and FGF‑2 mediating musculoskeletal crosstalk molecular signaling pathway on bone metabolism (Review). | Int J Mol Med | 2026 | 41574692 | PubTator, text mining | PubMed |
| NCOA1 is a gatekeeper of the sexually dimorphic thermogenic activity of white adipose tissue. | Nat Commun | 2026 | 41559022 | PubTator, text mining | PubMed |
| A promising magnesium-related alloy with metabolic reprogramming and antitumor effects in hepatocellular and pancreatic cancer. | Bioact Mater | 2026 | 41536919 | PubTator, text mining | PubMed |
| Multiomics Integration Analysis Reveals the Regulatory Mechanisms of Efferocytosis in Diabetic Kidney Disease. | Inflammation | 2026 | 41528564 | PubTator, text mining | PubMed |
| Pharmacological inhibition of miR-126 enhances venetoclax activity in acute myeloid leukemia. | Blood | 2026 | 41397241 | PubTator, text mining | PubMed |
| Rewiring lipid Metabolism: The central role of CPT1 in metabolic dysfunction. | Prog Biophys Mol Biol | 2026 | 41274422 | PubTator, text mining | PubMed |
| Acute Inhalation Exposure to Ultrafine Carbon Black Alters Mitochondrial Substrate Utilization in the Heart. | Environ Toxicol | 2026 | 41171173 | PubTator, text mining | PubMed |
| Evolutionary divergence and functional insights into the heteromeric cis-prenyltransferase of Paramecium tetraurelia. | FEBS J | 2026 | 40847593 | PubTator, text mining | PubMed |
| A cross-tissue transcriptome-wide association study reveals novel susceptibility genes for erectile dysfunction. | Andrology | 2026 | 40145662 | PubTator, text mining | PubMed |
| Effects of probiotic supplementation on growth and meat quality of Simmental bulls. | Front Vet Sci | 2025 | 41767958 | PubTator, text mining | PubMed |
| Targeted lipidomics meets transcriptomics: how cinobufagin rewires fatty acid, sphingolipid, and glycerophospholipid metabolism to combat hepatoma cell growth. | Front Pharmacol | 2025 | 41737012 | PubTator, text mining | PubMed |
| Review of Hyperbaric Oxygen Therapy as an Adjunctive Intervention for Metabolic Disorders. | Antioxidants (Basel) | 2025 | 41462642 | PubTator, text mining | PubMed |
| A 25-Year Retrospective on Bavaria's Newborn Screening Programme: Achievements, Challenges and Long-Term Follow-Up. | Int J Neonatal Screen | 2025 | 41440810 | PubTator, text mining | PubMed |
| (-)-Guaiol Downregulates M2 Tumor-Associated Macrophage Polarization Through PPAR-γ Signaling to Suppress Lung Cancer. | Biol Proced Online | 2025 | 41350836 | PubTator, text mining | PubMed |
| Enzymes of the outer mitochondrial membrane regulating cholesterol and fatty acid metabolism in cancer. | Adv Cancer Res | 2025 | 41242858 | PubTator, text mining | PubMed |
| Extracellular vesicles in metabolic perspective: mechanism and targeted therapy. | J Nanobiotechnology | 2025 | 41084004 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1375/papers?page=2